Intelligent Traffic Management System (ITMS)
Intelligent Traffic Management System (ITMS) market is segmented by players, region (country), by ... Read More
Global Opioids Market Insights and Forecast to 2028
1 Study Coverage
1.1 Opioids Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market by Application
1.3.1 Global Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioids Sales Estimates and Forecasts 2017-2028
2.2 Global Opioids Revenue Estimates and Forecasts 2017-2028
2.3 Global Opioids Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Opioids Sales by Region
2.4.1 Global Opioids Sales by Region (2017-2022)
2.4.2 Global Sales Opioids by Region (2023-2028)
2.5 Global Opioids Revenue by Region
2.5.1 Global Opioids Revenue by Region (2017-2022)
2.5.2 Global Opioids Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Opioids Sales by Manufacturers
3.1.1 Global Top Opioids Manufacturers by Sales (2017-2022)
3.1.2 Global Opioids Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioids in 2021
3.2 Global Opioids Revenue by Manufacturers
3.2.1 Global Opioids Revenue by Manufacturers (2017-2022)
3.2.2 Global Opioids Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Opioids Revenue in 2021
3.3 Global Opioids Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Opioids Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Opioids Sales by Type
4.1.1 Global Opioids Historical Sales by Type (2017-2022)
4.1.2 Global Opioids Forecasted Sales by Type (2023-2028)
4.1.3 Global Opioids Sales Market Share by Type (2017-2028)
4.2 Global Opioids Revenue by Type
4.2.1 Global Opioids Historical Revenue by Type (2017-2022)
4.2.2 Global Opioids Forecasted Revenue by Type (2023-2028)
4.2.3 Global Opioids Revenue Market Share by Type (2017-2028)
4.3 Global Opioids Price by Type
4.3.1 Global Opioids Price by Type (2017-2022)
4.3.2 Global Opioids Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Opioids Sales by Application
5.1.1 Global Opioids Historical Sales by Application (2017-2022)
5.1.2 Global Opioids Forecasted Sales by Application (2023-2028)
5.1.3 Global Opioids Sales Market Share by Application (2017-2028)
5.2 Global Opioids Revenue by Application
5.2.1 Global Opioids Historical Revenue by Application (2017-2022)
5.2.2 Global Opioids Forecasted Revenue by Application (2023-2028)
5.2.3 Global Opioids Revenue Market Share by Application (2017-2028)
5.3 Global Opioids Price by Application
5.3.1 Global Opioids Price by Application (2017-2022)
5.3.2 Global Opioids Price Forecast by Application (2023-2028)
6 North America
6.1 North America Opioids Market Size by Type
6.1.1 North America Opioids Sales by Type (2017-2028)
6.1.2 North America Opioids Revenue by Type (2017-2028)
6.2 North America Opioids Market Size by Application
6.2.1 North America Opioids Sales by Application (2017-2028)
6.2.2 North America Opioids Revenue by Application (2017-2028)
6.3 North America Opioids Market Size by Country
6.3.1 North America Opioids Sales by Country (2017-2028)
6.3.2 North America Opioids Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Opioids Market Size by Type
7.1.1 Europe Opioids Sales by Type (2017-2028)
7.1.2 Europe Opioids Revenue by Type (2017-2028)
7.2 Europe Opioids Market Size by Application
7.2.1 Europe Opioids Sales by Application (2017-2028)
7.2.2 Europe Opioids Revenue by Application (2017-2028)
7.3 Europe Opioids Market Size by Country
7.3.1 Europe Opioids Sales by Country (2017-2028)
7.3.2 Europe Opioids Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioids Market Size by Type
8.1.1 Asia Pacific Opioids Sales by Type (2017-2028)
8.1.2 Asia Pacific Opioids Revenue by Type (2017-2028)
8.2 Asia Pacific Opioids Market Size by Application
8.2.1 Asia Pacific Opioids Sales by Application (2017-2028)
8.2.2 Asia Pacific Opioids Revenue by Application (2017-2028)
8.3 Asia Pacific Opioids Market Size by Region
8.3.1 Asia Pacific Opioids Sales by Region (2017-2028)
8.3.2 Asia Pacific Opioids Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Opioids Market Size by Type
9.1.1 Latin America Opioids Sales by Type (2017-2028)
9.1.2 Latin America Opioids Revenue by Type (2017-2028)
9.2 Latin America Opioids Market Size by Application
9.2.1 Latin America Opioids Sales by Application (2017-2028)
9.2.2 Latin America Opioids Revenue by Application (2017-2028)
9.3 Latin America Opioids Market Size by Country
9.3.1 Latin America Opioids Sales by Country (2017-2028)
9.3.2 Latin America Opioids Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Opioids Market Size by Type
10.1.1 Middle East and Africa Opioids Sales by Type (2017-2028)
10.1.2 Middle East and Africa Opioids Revenue by Type (2017-2028)
10.2 Middle East and Africa Opioids Market Size by Application
10.2.1 Middle East and Africa Opioids Sales by Application (2017-2028)
10.2.2 Middle East and Africa Opioids Revenue by Application (2017-2028)
10.3 Middle East and Africa Opioids Market Size by Country
10.3.1 Middle East and Africa Opioids Sales by Country (2017-2028)
10.3.2 Middle East and Africa Opioids Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Corporation Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Purdue Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Purdue Pharma Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mallinckrodt Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mallinckrodt Recent Developments
11.4 Amneal Pharma
11.4.1 Amneal Pharma Corporation Information
11.4.2 Amneal Pharma Overview
11.4.3 Amneal Pharma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amneal Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amneal Pharma Recent Developments
11.5 Collegium
11.5.1 Collegium Corporation Information
11.5.2 Collegium Overview
11.5.3 Collegium Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Collegium Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Collegium Recent Developments
11.6 J&J
11.6.1 J&J Corporation Information
11.6.2 J&J Overview
11.6.3 J&J Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 J&J Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 J&J Recent Developments
11.7 Endo
11.7.1 Endo Corporation Information
11.7.2 Endo Overview
11.7.3 Endo Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 INSYS
11.9.1 INSYS Corporation Information
11.9.2 INSYS Overview
11.9.3 INSYS Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 INSYS Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 INSYS Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Hikma
11.11.1 Hikma Corporation Information
11.11.2 Hikma Overview
11.11.3 Hikma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hikma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hikma Recent Developments
11.12 Egalet
11.12.1 Egalet Corporation Information
11.12.2 Egalet Overview
11.12.3 Egalet Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Egalet Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Egalet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Opioids Industry Chain Analysis
12.2 Opioids Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioids Production Mode & Process
12.4 Opioids Sales and Marketing
12.4.1 Opioids Sales Channels
12.4.2 Opioids Distributors
12.5 Opioids Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Opioids Industry Trends
13.2 Opioids Market Drivers
13.3 Opioids Market Challenges
13.4 Opioids Market Restraints
14 Key Findings in The Global Opioids Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Major Manufacturers of Other
Table 7. Global Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Opioids Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Opioids Sales by Region (2017-2022) & (MT)
Table 10. Global Opioids Sales Market Share by Region (2017-2022)
Table 11. Global Opioids Sales by Region (2023-2028) & (MT)
Table 12. Global Opioids Sales Market Share by Region (2023-2028)
Table 13. Global Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Opioids Revenue Market Share by Region (2017-2022)
Table 15. Global Opioids Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Opioids Revenue Market Share by Region (2023-2028)
Table 17. Global Opioids Sales by Manufacturers (2017-2022) & (MT)
Table 18. Global Opioids Sales Share by Manufacturers (2017-2022)
Table 19. Global Opioids Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Opioids Revenue Share by Manufacturers (2017-2022)
Table 21. Opioids Price by Manufacturers (2017-2022) &(USD/Kg)
Table 22. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2021)
Table 24. Opioids Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Opioids Product Offered
Table 26. Date of Manufacturers Enter into Opioids Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Opioids Sales by Type (2017-2022) & (MT)
Table 29. Global Opioids Sales by Type (2023-2028) & (MT)
Table 30. Global Opioids Sales Share by Type (2017-2022)
Table 31. Global Opioids Sales Share by Type (2023-2028)
Table 32. Global Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Opioids Revenue Share by Type (2017-2022)
Table 35. Global Opioids Revenue Share by Type (2023-2028)
Table 36. Opioids Price by Type (2017-2022) & (USD/Kg)
Table 37. Global Opioids Price Forecast by Type (2023-2028) & (USD/Kg)
Table 38. Global Opioids Sales by Application (2017-2022) & (MT)
Table 39. Global Opioids Sales by Application (2023-2028) & (MT)
Table 40. Global Opioids Sales Share by Application (2017-2022)
Table 41. Global Opioids Sales Share by Application (2023-2028)
Table 42. Global Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Opioids Revenue Share by Application (2017-2022)
Table 45. Global Opioids Revenue Share by Application (2023-2028)
Table 46. Opioids Price by Application (2017-2022) & (USD/Kg)
Table 47. Global Opioids Price Forecast by Application (2023-2028) & (USD/Kg)
Table 48. North America Opioids Sales by Type (2017-2022) & (MT)
Table 49. North America Opioids Sales by Type (2023-2028) & (MT)
Table 50. North America Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Opioids Sales by Application (2017-2022) & (MT)
Table 53. North America Opioids Sales by Application (2023-2028) & (MT)
Table 54. North America Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Opioids Sales by Country (2017-2022) & (MT)
Table 57. North America Opioids Sales by Country (2023-2028) & (MT)
Table 58. North America Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Opioids Sales by Type (2017-2022) & (MT)
Table 61. Europe Opioids Sales by Type (2023-2028) & (MT)
Table 62. Europe Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Opioids Sales by Application (2017-2022) & (MT)
Table 65. Europe Opioids Sales by Application (2023-2028) & (MT)
Table 66. Europe Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Opioids Sales by Country (2017-2022) & (MT)
Table 69. Europe Opioids Sales by Country (2023-2028) & (MT)
Table 70. Europe Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Opioids Sales by Type (2017-2022) & (MT)
Table 73. Asia Pacific Opioids Sales by Type (2023-2028) & (MT)
Table 74. Asia Pacific Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Opioids Sales by Application (2017-2022) & (MT)
Table 77. Asia Pacific Opioids Sales by Application (2023-2028) & (MT)
Table 78. Asia Pacific Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Opioids Sales by Region (2017-2022) & (MT)
Table 81. Asia Pacific Opioids Sales by Region (2023-2028) & (MT)
Table 82. Asia Pacific Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Opioids Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Opioids Sales by Type (2017-2022) & (MT)
Table 85. Latin America Opioids Sales by Type (2023-2028) & (MT)
Table 86. Latin America Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Opioids Sales by Application (2017-2022) & (MT)
Table 89. Latin America Opioids Sales by Application (2023-2028) & (MT)
Table 90. Latin America Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Opioids Sales by Country (2017-2022) & (MT)
Table 93. Latin America Opioids Sales by Country (2023-2028) & (MT)
Table 94. Latin America Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Opioids Sales by Type (2017-2022) & (MT)
Table 97. Middle East and Africa Opioids Sales by Type (2023-2028) & (MT)
Table 98. Middle East and Africa Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Opioids Sales by Application (2017-2022) & (MT)
Table 101. Middle East and Africa Opioids Sales by Application (2023-2028) & (MT)
Table 102. Middle East and Africa Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Opioids Sales by Country (2017-2022) & (MT)
Table 105. Middle East and Africa Opioids Sales by Country (2023-2028) & (MT)
Table 106. Middle East and Africa Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 108. Teva Corporation Information
Table 109. Teva Description and Major Businesses
Table 110. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 111. Teva Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Teva Recent Developments
Table 113. Purdue Pharma Corporation Information
Table 114. Purdue Pharma Description and Major Businesses
Table 115. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 116. Purdue Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Purdue Pharma Recent Developments
Table 118. Mallinckrodt Corporation Information
Table 119. Mallinckrodt Description and Major Businesses
Table 120. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 121. Mallinckrodt Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Mallinckrodt Recent Developments
Table 123. Amneal Pharma Corporation Information
Table 124. Amneal Pharma Description and Major Businesses
Table 125. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 126. Amneal Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Amneal Pharma Recent Developments
Table 128. Collegium Corporation Information
Table 129. Collegium Description and Major Businesses
Table 130. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 131. Collegium Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Collegium Recent Developments
Table 133. J&J Corporation Information
Table 134. J&J Description and Major Businesses
Table 135. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 136. J&J Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. J&J Recent Developments
Table 138. Endo Corporation Information
Table 139. Endo Description and Major Businesses
Table 140. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 141. Endo Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Endo Recent Developments
Table 143. Pfizer Corporation Information
Table 144. Pfizer Description and Major Businesses
Table 145. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 146. Pfizer Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Pfizer Recent Developments
Table 148. INSYS Corporation Information
Table 149. INSYS Description and Major Businesses
Table 150. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 151. INSYS Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. INSYS Recent Developments
Table 153. Mylan Corporation Information
Table 154. Mylan Description and Major Businesses
Table 155. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 156. Mylan Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Mylan Recent Developments
Table 158. Hikma Corporation Information
Table 159. Hikma Description and Major Businesses
Table 160. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 161. Hikma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Hikma Recent Developments
Table 163. Egalet Corporation Information
Table 164. Egalet Description and Major Businesses
Table 165. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 166. Egalet Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Egalet Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Opioids Distributors List
Table 171. Opioids Customers List
Table 172. Opioids Market Trends
Table 173. Opioids Market Drivers
Table 174. Opioids Market Challenges
Table 175. Opioids Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 3. Global Opioids Market Share by Type in 2021 & 2028
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Market Share by Application in 2021 & 2028
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Cough Suppression
Figure 12. Diarrhea Suppression
Figure 13. Deaddiction
Figure 14. Others
Figure 15. Opioids Report Years Considered
Figure 16. Global Opioids Sales 2017-2028 (MT)
Figure 17. Global Opioids Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Opioids Revenue 2017-2028 (US$ Million)
Figure 19. Global Opioids Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Opioids Sales Market Share by Region (2017-2022)
Figure 21. Global Opioids Sales Market Share by Region (2023-2028)
Figure 22. North America Opioids Sales YoY (2017-2028) & (MT)
Figure 23. North America Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Opioids Sales YoY (2017-2028) & (MT)
Figure 25. Europe Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Opioids Sales YoY (2017-2028) & (MT)
Figure 27. Asia-Pacific Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Opioids Sales YoY (2017-2028) & (MT)
Figure 29. Latin America Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Opioids Sales YoY (2017-2028) & (MT)
Figure 31. Middle East & Africa Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Opioids Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Opioids in the World: Market Share by Opioids Revenue in 2021
Figure 34. Global Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Opioids Sales Market Share by Type (2017-2028)
Figure 36. Global Opioids Revenue Market Share by Type (2017-2028)
Figure 37. Global Opioids Sales Market Share by Application (2017-2028)
Figure 38. Global Opioids Revenue Market Share by Application (2017-2028)
Figure 39. North America Opioids Sales Market Share by Type (2017-2028)
Figure 40. North America Opioids Revenue Market Share by Type (2017-2028)
Figure 41. North America Opioids Sales Market Share by Application (2017-2028)
Figure 42. North America Opioids Revenue Market Share by Application (2017-2028)
Figure 43. North America Opioids Sales Share by Country (2017-2028)
Figure 44. North America Opioids Revenue Share by Country (2017-2028)
Figure 45. U.S. Opioids Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Opioids Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Opioids Sales Market Share by Type (2017-2028)
Figure 48. Europe Opioids Revenue Market Share by Type (2017-2028)
Figure 49. Europe Opioids Sales Market Share by Application (2017-2028)
Figure 50. Europe Opioids Revenue Market Share by Application (2017-2028)
Figure 51. Europe Opioids Sales Share by Country (2017-2028)
Figure 52. Europe Opioids Revenue Share by Country (2017-2028)
Figure 53. Germany Opioids Revenue (2017-2028) & (US$ Million)
Figure 54. France Opioids Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Opioids Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Opioids Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Opioids Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Opioids Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Opioids Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Opioids Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Opioids Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Opioids Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Opioids Revenue Share by Region (2017-2028)
Figure 64. China Opioids Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Opioids Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Opioids Revenue (2017-2028) & (US$ Million)
Figure 67. India Opioids Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Opioids Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Opioids Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Opioids Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Opioids Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Opioids Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Opioids Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Opioids Sales Market Share by Type (2017-2028)
Figure 75. Latin America Opioids Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Opioids Sales Market Share by Application (2017-2028)
Figure 77. Latin America Opioids Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Opioids Sales Share by Country (2017-2028)
Figure 79. Latin America Opioids Revenue Share by Country (2017-2028)
Figure 80. Mexico Opioids Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Opioids Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Opioids Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Opioids Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Opioids Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Opioids Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Opioids Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Opioids Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Opioids Revenue Share by Country (2017-2028)
Figure 89. Turkey Opioids Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Opioids Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Opioids Revenue (2017-2028) & (US$ Million)
Figure 92. Opioids Value Chain
Figure 93. Opioids Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva Purdue Pharma Mallinckrodt Amneal Pharma Collegium J&J Endo Pfizer INSYS Mylan Hikma Egalet